AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Merck & Co. Inc. (MRK)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

97.68

-0.26 (-0.27%)

At close: Jan 28, 2025, 2:01 PM

Merck & Co. Inc. Revenue Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014
Animal Health segment Revenue	1.49B	1.48B	1.51B	14.26B	1.46B	1.49B	1.23B	1.37B	1.47B	1.48B	1.26B	1.42B	1.47B	1.42B	1.17B	1.22B	1.10B	1.21B	1.12B	1.12B	1.12B	1.02B	1.04B	1.02B	1.09B	8.92B	9.29B	9.16B	8.76B	8.19B	8.90B	9.44B	8.70B	8.10B	9.03B	8.93B	8.56B	8.27B	9.37B	9.13B	9.09B	8.45B
Animal Health segment Revenue Growth	+0.34%	-1.92%	-89.41%	+879.60%	-2.35%	+21.22%	-10.28%	-6.54%	-1.01%	+17.53%	-11.01%	-3.74%	+3.81%	+21.40%	-4.26%	+10.81%	-9.31%	+8.20%	0.00%	-0.18%	+9.66%	-1.06%	+1.47%	-6.33%	-87.78%	-3.99%	+1.46%	+4.53%	+7.01%	-8.08%	-5.71%	+8.54%	+7.35%	-10.22%	+1.14%	+4.22%	+3.61%	-11.78%	+2.58%	+0.52%	+7.53%	n/a
Pharmaceutical segment Revenue	14.94B	14.41B	14.01B	1.40B	13.46B	12.72B	12.18B	12.96B	12.76B	14.11B	10.60B	11.50B	9.98B	10.68B	11.37B	11.32B	9.68B	10.65B	10.53B	11.10B	10.46B	9.66B	9.83B	9.66B	9.28B	1.06B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pharmaceutical segment Revenue Growth	+3.71%	+2.87%	+900.43%	-89.60%	+5.79%	+4.45%	-6.05%	+1.62%	-9.58%	+33.05%	-7.77%	+15.19%	-6.51%	-6.09%	+0.42%	+16.95%	-9.16%	+1.16%	-5.07%	+6.07%	+8.25%	-1.70%	+1.78%	+4.05%	+771.55%	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a

Revenue by Geography

Quarter	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Asia Pacific Revenue	12.43B	9.51B	9.86B	9.73B	8.30B	17.42B	6.76B	6.49B	7.42B	7.89B	20.39B	20.50B	20.23B
Asia Pacific Revenue Growth	+30.73%	-3.58%	+1.35%	+17.19%	-52.34%	+157.60%	+4.17%	-12.52%	-5.92%	-61.31%	-0.50%	+1.33%	n/a
Emea Revenue	14.49B	13.34B	13.60B	12.71B	12.21B	7.46B	10.95B	10.68B	13.17B	13.14B	12.99B	4.83B	13.50B
Emea Revenue Growth	+8.64%	-1.90%	+7.03%	+4.04%	+63.74%	-31.90%	+2.58%	-18.95%	+0.26%	+1.15%	+168.67%	-64.18%	n/a
Latin America Revenue	2.58B	2.21B	2.27B	2.47B	2.42B	11.48B	2.15B	2.82B	3.15B	3.20B	5.10B	n/a	3.77B
Latin America Revenue Growth	+17.04%	-2.99%	-7.90%	+2.24%	-78.96%	+432.62%	-23.66%	-10.41%	-1.62%	-37.22%	n/a	n/a	n/a
United States Revenue	27.21B	22.43B	21.03B	20.32B	18.21B	2.34B	18.48B	17.52B	17.07B	18.25B	n/a	n/a	n/a
United States Revenue Growth	+21.32%	+6.65%	+3.45%	+11.60%	+678.62%	-87.34%	+5.47%	+2.62%	-6.44%	n/a	n/a	n/a	n/a

Operating Expense Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015
Selling, General, and Administrative Revenue	2.73B	2.71B	2.48B	2.80B	2.52B	2.70B	2.48B	2.69B	2.52B	2.51B	2.32B	2.83B	2.34B	2.28B	2.19B	3.08B	2.06B	2.08B	2.56B	2.89B	2.59B	2.71B	2.42B	2.64B	2.44B	2.51B	2.51B	2.58B	2.46B	2.50B	2.47B	2.59B	2.39B	2.46B	2.32B	2.62B	2.47B	2.62B	2.60B
Selling, General, and Administrative Revenue Growth	+0.85%	+9.06%	-11.45%	+11.31%	-6.77%	+9.00%	-7.74%	+6.63%	+0.32%	+8.14%	-17.92%	+21.15%	+2.41%	+4.30%	-29.11%	+49.76%	-1.20%	-18.40%	-11.56%	+11.59%	-4.54%	+11.84%	-8.25%	+8.19%	-2.59%	n/a	-2.75%	+4.88%	-1.64%	+1.13%	-4.67%	+8.36%	-2.64%	+6.04%	-11.36%	+5.78%	-5.79%	+0.88%	n/a
Research and Development Revenue	5.86B	2.89B	3.99B	9.63B	3.31B	13.32B	4.28B	3.77B	4.40B	2.80B	2.58B	3.07B	2.44B	4.32B	2.41B	5.84B	3.35B	2.08B	2.21B	2.55B	3.20B	2.19B	1.93B	2.21B	2.07B	2.27B	3.20B	2.28B	4.41B	1.78B	1.83B	4.65B	1.66B	2.15B	1.66B	1.80B	1.50B	1.67B	1.74B
Research and Development Revenue Growth	+103.12%	-27.71%	-58.53%	+191.11%	-75.17%	+211.53%	+13.27%	-14.19%	+57.22%	+8.62%	-16.04%	+25.48%	-43.42%	+79.15%	-58.68%	+74.29%	+60.62%	-5.61%	-13.30%	-20.47%	+46.37%	+13.36%	-12.78%	+7.06%	-9.06%	-28.85%	+40.11%	-48.31%	+147.64%	-2.62%	-60.64%	+179.39%	-22.64%	+29.66%	-7.73%	+19.87%	-10.18%	-3.86%	n/a